Neurosense Therapeutics Ltd. (NRSN)
2.46
+0.02
(+0.82%)
USD |
NASDAQ |
Oct 23, 16:00
2.43
-0.03
(-1.22%)
After-Hours: 20:00
Neurosense Therapeutics Market Cap : 80.09M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 80.09M |
| October 22, 2026 | 79.44M |
| October 21, 2026 | 83.35M |
| October 20, 2026 | 77.81M |
| October 19, 2026 | 86.76M |
| October 16, 2026 | 99.95M |
| October 15, 2026 | 103.21M |
| October 14, 2026 | 99.62M |
| October 13, 2026 | 113.62M |
| October 12, 2026 | 113.30M |
| October 09, 2026 | 119.16M |
| October 08, 2026 | 116.55M |
| October 07, 2026 | 124.37M |
| October 06, 2026 | 132.51M |
| October 05, 2026 | 131.21M |
| October 02, 2026 | 128.11M |
| October 01, 2026 | 131.86M |
| September 30, 2026 | 144.23M |
| September 29, 2026 | 155.62M |
| September 28, 2026 | 166.04M |
| September 25, 2026 | 226.27M |
| September 24, 2026 | 240.92M |
| September 23, 2026 | 240.92M |
| September 22, 2026 | 233.76M |
| September 21, 2026 | 215.53M |
| Date | Value |
|---|---|
| September 18, 2026 | 206.74M |
| September 17, 2026 | 218.78M |
| September 16, 2026 | 211.30M |
| September 15, 2026 | 228.88M |
| September 14, 2026 | 224.64M |
| September 11, 2026 | 226.08M |
| September 10, 2026 | 216.18M |
| September 09, 2026 | 261.11M |
| September 08, 2026 | 194.24M |
| September 04, 2026 | 237.31M |
| September 03, 2026 | 186.57M |
| September 02, 2026 | 190.85M |
| September 01, 2026 | 195.17M |
| August 31, 2026 | 198.24M |
| August 28, 2026 | 195.31M |
| August 27, 2026 | 203.90M |
| August 26, 2026 | 190.01M |
| August 25, 2026 | 177.61M |
| August 24, 2026 | 174.22M |
| August 21, 2026 | 174.82M |
| August 20, 2026 | 162.79M |
| August 19, 2026 | 184.90M |
| August 18, 2026 | 177.47M |
| August 17, 2026 | 200.70M |
| August 14, 2026 | 210.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 8.911M |
| XTL Biopharmaceuticals Ltd. | 4.778M |
| Kamada Ltd. | 448.28M |
| Can-Fite BioPharma Ltd. | 3.814M |
| Eocene Ltd. | 3.034M |
Market Cap Related Metrics
| Price | 2.46 |